News search

A CNIC-led study identifies a mitochondrial “checkpoint” that enables dendritic cells to efficiently activate T lymphocytes against viruses and tumors

Scientist at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) and the Institute for Research in Biomedicine (IRB Barcelona) uncover a key metabolic mechanism governing immune cell readiness

TARGET-DC, CNIC initiative led by Dr. David Sancho aims to identify novel immune checkpoints in dendritic cells to advance T-cell activation.

The Young Author Achievement Award recognises her research into cardiotoxicity published in JACC: Cardio-Oncology

Justin Perry, Associate Member in the Immunology Program of the Sloan Kettering Institute at Memorial Sloan Kettering Cancer Center and an Assistant Professor in the Immunology and Microbial Pathogenesis Program at Weill Cornell Medical Center

A new CNIC-led study shows that a genetic tool derived from baker’s yeast enables human cells to manufacture the building blocks of DNA even when their mitochondria fail.